Jianjun Zou, MD, PhD
Jiangsu HengRui Medicine Co., Ltd.
2
0
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Shun Lu, MD, PhD
Jiaotong University,Shanghai chest Hospital
Shared therapeutic areas:
Worked with same sponsors:
Caicun Zhou, MD, PhD
Tongji University, Shanghai Pulmonary Hospital
Shared therapeutic areas:
Worked with same sponsors:
Herui Yao, PhD
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Shared therapeutic areas:
Elif Yıldırım Ayaz, M.D.
Sultan Abdülhamid Training And Research Hospital
Shared therapeutic areas:
Qijun Qian
Shanghai Cell Therapy Research Institute
Shared therapeutic areas:
Emil Kuriakose, MD
Calithera Biosciences, Inc
Shared therapeutic areas:
Zhengfei Zhu, MD
Fudan University
Shared therapeutic areas:
Zhenggang Zhu
Ruijin Hospital
Shared therapeutic areas:
Chen Li, PH D
Ruijin Hospital
Shared therapeutic areas:
Sarina A Piha-Paul
M.D. Anderson Cancer Center
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Phase II Study of SHR-1210(Anti-PD-1 Antibody) Combination With Apatinib Versus Pemetrexed and Carboplatin in Subjects With KRAS Mutant Stage IV Non-squamous Non-small Cell Lung Cancer
A Study of SHR-1210 in Combination With Carboplatin + Paclitaxel in Subjects With Squamous NSCLC
All 2 trials loaded